Striving for
Seizure Control
Without the Side Effects

NeuroPro Therapeutics is a clinical-stage pharmaceutical company actively developing novel compounds to treat neurologic diseases, including epilepsy.

patient design element for biotech website

for patients

Clinical trails planned in 2024.

Contact your provider to learn about combining your current epilepsy treatment with a new antiepileptic drug candidate.

stethoscope design element for biotech website

for providers

Redefining epilepsy treatment. Improving lives.

Learn more about enrolling your epilepsy patients in our Phase 2 clinical trial.

Our Lead Antiepileptic Drug Candidate

30% of epilepsy population/ unmet medical need. Proof of efficacy with similar results to bumetanide and furosemide (NKCC antagonists) in two pharmacology models.